B

BillionToOne

269 employees

BillionToOne is a precision diagnostics company focused on genetic testing for disease detection.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Genetics
Medical

Date founded

2016

Funding rounds raised

Total raised

$125M

from 43 investors over 43 rounds

B

BillionToOne raised $49M on December 15, 2022

Investors: Libertus Capital, Time BioVentures, Adams Street Partners, Neotribe Ventures, Baillie Gifford, Norwest Venture Partners and Hummingbird Ventures

B

BillionToOne raised $35M on December 15, 2022

Investors: Bridge Bank

B

BillionToOne raised $125M on March 30, 2022

Investors: Hummingbird Ventures, Neotribe Ventures, Libertus Capital, Time BioVentures, Pacific 8 Ventures, Norwest Venture Partners, Adams Street Partners, Baillie Gifford and Civilization Ventures

B

BillionToOne raised $55M on June 15, 2021

Investors: Libertus Capital, Neotribe Ventures, Y Combinator, Norwest Venture Partners, 500 Startups and Hummingbird Ventures

B

BillionToOne raised $15M on March 10, 2020

Investors: Libertus Capital, HOF Capital, Hummingbird Ventures, Neotribe Ventures, Civilization Ventures, Y Combinator and Pacific 8 Ventures

B

BillionToOne raised undisclosed on February 6, 2020

Investors: 500 Startups

B

BillionToOne raised $15M on March 13, 2019

Investors: Neotribe Ventures, HOF Capital, Civilization Ventures, 500 Startups, Y Combinator and Hummingbird Ventures

B

BillionToOne raised $2.4M on September 15, 2017

Investors: Endpoint Ventures, UpHonest Capital, NewDo Venture and Pacific 8 Ventures

B

BillionToOne raised undisclosed on August 21, 2017

Investors: Endpoint Ventures and Y Combinator

FAQ